The dual HDAC and PI3K inhibitor, CUDC‑907, inhibits tumor growth and stem‑like properties by suppressing PTX3 in neuroblastoma-Reference-Cited by-同舟云学术

The dual HDAC and PI3K inhibitor, CUDC‑907, inhibits tumor growth and stem‑like properties by suppressing PTX3 in neuroblastoma

Published:2023-12-08 Issue:2 Volume:64 Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Li Mengzhen¹,Hu Yang¹,Wang Juan¹,Xu Yanjie¹,Hong Ye¹,Zhang Li¹,Luo Qiuyun²,Zhen Zijun¹,Lu Suying¹,Huang Junting¹,Zhu Jia¹,Zhang Yizhuo¹,Que Yi¹,Sun Feifei¹

Affiliation:

1. Department of Pediatric Oncology, Sun Yat‑sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China

2. State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat‑sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference60 articles.

1. Neuroblastoma;Maris;Lancet,2007

2. Overview and recent advances in the treatment of neuroblastoma;Whittle;Expert Rev Anticancer Ther,2017

3. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma;Yu;N Engl J Med,2010

4. Dinutuximab for maintenance therapy in pediatric neuroblastoma;McGinty;Am J Health Syst Pharm,2017

5. Mutational dynamics between primary and relapse neuroblastomas;Schramm;Nat Genet,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the molecular mechanisms of Fuzheng Yiliu Shenji prescription in SH-SY5Y neuroblastoma cells;Frontiers in Oncology;2024-09-10